Pharmafile Logo
Pharmafocus logo
Advanced Search
merck-keytruda

MSD’s Keytruda misses the mark at Phase 3 in advanced bladder cancer

June 11, 2020
Research and Development MSD< Keytruda, bladder cancer, pharma, trial failure

MSD has announced the disappointing findings that its anti-PD-1 immunotherapy Keytruda (pembrolizumab), when used either alone or combined with chemotherapy, …

News
eli_lilly

Eli Lilly’s coronavirus antibody treatments could be available by September

June 11, 2020
Business Services COVID, COVID-19, coronavirus

An antibody therapy for coronavirus could be available from Eli Lilly as early as September, according to one of its …

News
shutterstock_273326141

AbbVie and Genmab sign drug development and commercialisation deal worth up to $4bn

June 11, 2020
Research and Development AbbVie, Genmab, partnership, pharma

AbbVie has joined forces with Genmab to develop and commercialise three of the latter’s early-stage Genmab drug products – epcoritamab …

News

Leading pharmaceutical companies sued in US for conspiring to drive up generics prices

June 11, 2020
Business Services drugs, generics, lawsuit, price fixing, price-fixing

26 pharmaceutical companies are being sued by most US states for allegedly conspiring to reduce competition and drive up generic …

News
capture

How digital therapeutics are revolutionising healthcare

June 10, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing digital therapeutics, feature, pharma

Digital health covers everything from algorithms identifying new drug combinations, to mobile phone apps to help patient adherence. The past …

Feature
cedrik_britten

Ex-GSK exec named as Chief Medical Officer at Immatics Biotechnologies

June 10, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, appointment, immatics

Immatics Biotechnologies welcomed former GlaxoSmithKline executive Dr Cedrik Britten to the company as its new Chief Medical Officer (CMO) on …

Appointment
nhsyyy

Number of people waiting for NHS treatment could double to 10 million due to pandemic

June 10, 2020
Research and Development COVID-19, coronavirus

The backlog of people waiting for treatment on the NHS could reach as high as 10 million people by Christmas …

News
vertex-headquarters

Vertex scores EU approval for cystic fibrosis drug Kalydeco in R117H+ children and adolescents

June 10, 2020
Research and Development, Sales and Marketing Kalydeco, Vertex, cystic fibrosis, ivacaftor, pharma

Vertex has revealed that it has secured a new approval from the European Commission for its therapy Kalydeco (ivacaftor) in …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 10, 2020
Research and Development COVID-19, coronavirus, round up, top 10

Hydroxychloroquine as a potential coronavirus treatment continues to be a contentious issue, as a new study led by researchers at …

News

Lundbeck to restructure R&D, shedding up to 160 jobs

June 10, 2020
Manufacturing and Production, Research and Development Lundbeck, pharma, staff cuts

Danish neuroscience specialist Lundbeck has announced it will be implementing a restructure of its Research & Development operations – a …

News
triallyyy

US trial of ivermectin cuts coronavirus mortality by 40%

June 10, 2020
Research and Development COVID-19, coronavirus

A US clinical trial of the drug ivermectin found that it reduced the mortality rate of COVID-19 patients by 40%. …

News
remdesivir_ulrich_perrey

EMA could approve Gilead’s streamlined remdesivir application for COVID-19 “within weeks”

June 9, 2020
Manufacturing and Production, Sales and Marketing COVID-19, EU, Gilead, coronavirus, remdesivir

The European Medicines Agency has received the application from Gilead for the first conditional marketing authorisation (CMA) of its antiviral …

News
alnylam_credit_-_business_wire

Alnylam’s lumasiran hits main Phase 3 goal in rare renal disease primary hyperoxaluria type 1

June 9, 2020
Manufacturing and Production, Research and Development Alnylam, lumasiran, pharma, rare disease

Alnylam has presented promising new Phase 3 data at the European Renal Association-European Dialysis and Transplant Association International Congress for …

News
lockdowns

Coronavirus lockdowns prevented 3.1 million deaths throughout Europe, according to new study

June 9, 2020
Manufacturing and Production COVID-19, coronavirus, pandemic

The widespread lockdowns implemented throughout Europe are estimated to have prevented 3.1 million deaths from the COVID-19 pandemic. This is …

News
wuhan_e

COVID-19 could have emerged in Wuhan as early as August, new study speculates

June 9, 2020
Manufacturing and Production COVID-19, Wuhan, coronavirus

Coronavirus may have been spreading throughout Wuhan in August 2019, according to a new study. This research was carried out …

News
fda

FDA launches new pilot program to crack down on unapproved opioids sold online

June 9, 2020
Manufacturing and Production FDA, opiod crisis, opioids

The FDA is collaborating with the National Telecommunications and Information Administration (NTIA) to launch a pilot program to reduce the …

News
astrazeneca_sign_sky

AstraZeneca’s BTK inhibitor Calquence shows promise in aiding recovery of severe COVID-19 patients

June 8, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, Calquence, coronavirus, pharma

AstraZeneca has revealed more data in its efforts to find an effective therapy for those affected by the novel coronavirus.

News
nhs_hospit

Two-thirds of Britons with common life-threatening conditions have been denied care during pandemic

June 8, 2020
Sales and Marketing COVID, COVID-19, NHS, NHS England, coronavirus, pandemic

Nearly two-thirds of people in Britain have been denied care for common life-threatening conditions by the NHS, due to their …

News

US supply of Gilead’s remdesivir expected to run out by the end of June

June 8, 2020
Sales and Marketing

The US government will run out of their current supply of Gilead’s remdsivir by the end of the month, the …

News
shutterstock_2

Oxford Biomedica joins forces with UK’s Vaccines Manufacturing and Innovation Centre to scale up production of Oxford Uni’s COVID-19 vaccine

June 8, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Oxford BioMedica, University of Oxford, Vaccine, coronavirus, pharma

Oxford Biomedica has forged a five-year partnership with the Vaccines Manufacturing and Innovation Centre (VMIC) to work together to provide …

News
The Gateway to Local Adoption Series

Latest content

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026

European Medicines Agency recommended 104 medicines for approval in 2025

January 20, 2026